{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:17:19Z","timestamp":1779203839360,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072850"],"award-info":[{"award-number":["82072850"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271842"],"award-info":[{"award-number":["82271842"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Small and medium-sized science and technology enterprise innovation ability enhancement project"},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH009"],"award-info":[{"award-number":["ZR2023MH009"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010040","name":"Taishan Scholar Project of Shandong Province","doi-asserted-by":"publisher","award":["tsqn202306260"],"award-info":[{"award-number":["tsqn202306260"]}],"id":[{"id":"10.13039\/501100010040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The aggressive phenotype of prostate cancer (PCa) requires adaptation to androgen deprivation (AD) to progress into castration-resistant PCa (CRPC), including adaptation to AD-induced oxidative stress. However, our understanding of the oncogenes that maintain the redox balance during CRPC progression is limited. Here, we identified Bromodomain-containing protein 9 (BRD9) as a metabolic checkpoint for reprogramming cell metabolism to support tumor growth and impart a castration-resistant phenotype under metabolic and oxidative stress. Following oxidation, BRD9 recruited the nuclear transcription factor-Y A-subunit (NFYA) to induce glycogen phosphorylase L (PYGL) expression, which directed glucose utilization through the pentose phosphate pathway, generating NADPH, and promoting clearance of reactive oxygen species (ROS), thus maintaining redox balance. By disturbing redox homeostasis, BRD9 inhibition exerted oxidative pressure on PCa cells, sensitizing them to radiotherapy. This work identified BRD9 as a novel component in antioxidant reprogramming and indicates BRD9 targeting as a promising treatment strategy for PCa therapy.<\/jats:p>","DOI":"10.1038\/s41419-025-07561-9","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T03:04:19Z","timestamp":1745291059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prostate cancer exploits BRD9-driven metabolic reprogramming to shape the aggressive phenotype"],"prefix":"10.1038","volume":"16","author":[{"given":"Ye","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4803-6024","authenticated-orcid":false,"given":"Xinkai","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruojia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanhua","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luna","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-0212","authenticated-orcid":false,"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"7561_CR1","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.1200\/JCO.2005.03.4777","volume":"23","author":"HI Scher","year":"2005","unstructured":"Scher HI, Sawyers CL. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis. J Clin Oncol. 2005;23:8253\u201361.","journal-title":"J Clin Oncol"},{"key":"7561_CR2","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1210\/en.2013-1466","volume":"154","author":"N Sharifi","year":"2013","unstructured":"Sharifi N. Mechanisms of androgen receptor activation in castration-resistant prostate cancer. Endocrinology. 2013;154:4010\u20137.","journal-title":"Endocrinology"},{"key":"7561_CR3","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/0008-5472.CAN-07-5259","volume":"68","author":"B Kumar","year":"2008","unstructured":"Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK. Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008;68:1777\u201385.","journal-title":"Cancer Res"},{"key":"7561_CR4","first-page":"1890s","volume":"54","author":"DI Feig","year":"1994","unstructured":"Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res. 1994;54:1890s\u20134s.","journal-title":"Cancer Res"},{"key":"7561_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1006\/scdb.2001.0282","volume":"12","author":"IG Kirkinezos","year":"2001","unstructured":"Kirkinezos IG, Moraes CT. Reactive oxygen species and mitochondrial diseases. Semin Cell Dev Biol. 2001;12:449\u201357.","journal-title":"Semin Cell Dev Biol"},{"key":"7561_CR6","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/pros.20565","volume":"67","author":"K Shigemura","year":"2007","unstructured":"Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, et al. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells. Prostate. 2007;67:722\u201331.","journal-title":"Prostate"},{"key":"7561_CR7","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/onc.2009.322","volume":"29","author":"M Shiota","year":"2010","unstructured":"Shiota M, Yokomizo A, Tada Y, Inokuchi J, Kashiwagi E, Masubuchi D, et al. Castration resistance of prostate cancer cells caused by castration-induced oxidative stress through Twist1 and androgen receptor overexpression. Oncogene. 2010;29:237\u201350.","journal-title":"Oncogene"},{"key":"7561_CR8","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1093\/carcin\/22.11.1775","volume":"22","author":"XY Sun","year":"2001","unstructured":"Sun XY, Donald SP, Phang JM. Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells. Carcinogenesis. 2001;22:1775\u201380.","journal-title":"Carcinogenesis"},{"key":"7561_CR9","first-page":"96","volume":"4","author":"D Mondal","year":"2020","unstructured":"Mondal D, Narwani D, Notta S, Ghaffar D, Mardhekar N, Quadri SSA. Oxidative stress and redox signaling in CRPC progression: therapeutic potential of clinically-tested Nrf2-activators. Cancer Drug Resist. 2020;4:96\u2013124.","journal-title":"Cancer Drug Resist"},{"key":"7561_CR10","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.canlet.2008.12.011","volume":"282","author":"L Khandrika","year":"2009","unstructured":"Khandrika L, Kumar B, Koul S, Maroni P, Koul HK. Oxidative stress in prostate cancer. Cancer Lett. 2009;282:125\u201336.","journal-title":"Cancer Lett"},{"key":"7561_CR11","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1128\/MCB.19.4.2724","volume":"19","author":"DJ Murphy","year":"1999","unstructured":"Murphy DJ, Hardy S, Engel DA. Human SWI-SNF Component BRG1 represses transcription of the c-Fos gene. Mol Cell Biol. 1999;19:2724\u201333.","journal-title":"Mol Cell Biol"},{"key":"7561_CR12","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1074\/jbc.M009633200","volume":"276","author":"T Ito","year":"2001","unstructured":"Ito T, Yamauchi M, Nishina M, Yamamichi N, Mizutani T, Ui M, et al. Identification of SWI\u00b7SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos\/Jun dimers. J Biol Chem. 2001;276:2852\u20137.","journal-title":"J Biol Chem"},{"key":"7561_CR13","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/8811","volume":"22","author":"SW Cheng","year":"1999","unstructured":"Cheng SW, Davies KP, Yung E, Beltran RJ, Yu J, Kalpana GV. c-MYC interacts with INI1\/hSNF5 and requires the SWI\/SNF complex for transactivation function. Nat Genet. 1999;22:102\u20135.","journal-title":"Nat Genet"},{"key":"7561_CR14","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1073\/pnas.97.14.7748","volume":"97","author":"MW Strobeck","year":"2000","unstructured":"Strobeck MW, Knudsen KE, Fribourg AF, Decristofaro MF, Weissman BE, Imbalzano AN, et al. BRG-1 is required for RB-mediated cell cycle arrest. Proc Natl Acad Sci USA. 2000;97:7748\u201353.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7561_CR15","doi-asserted-by":"publisher","first-page":"22330","DOI":"10.1074\/jbc.M111987200","volume":"277","author":"L Daeyoup","year":"2002","unstructured":"Daeyoup L, Woo KJ, Taegun S, Gwan HS, Eui-Ju C, Joonho C. SWI\/SNF complex interacts with tumor suppressor p53 and is necessary for the activation of p53-mediated transcription. J Biol Chem. 2002;277:22330\u20137.","journal-title":"J Biol Chem"},{"key":"7561_CR16","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1093\/emboj\/20.17.4935","volume":"20","author":"N Barker","year":"2001","unstructured":"Barker N, Hurlstone A, Musisi H, Miles A, Bienz M, Clevers H. The chromatin remodelling factor Brg-1 interacts with beta-catenin to promote target gene activation. EMBO J. 2001;20:4935\u201343.","journal-title":"EMBO J"},{"key":"7561_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19328-1","volume":"11","author":"J Cyrta","year":"2020","unstructured":"Cyrta J, Augspach A, De Filippo MR, Prandi D, Thienger P, Benelli M, et al. Role of specialized composition of SWI\/SNF complexes in prostate cancer lineage plasticity. Nat Commun. 2020;11:5549.","journal-title":"Nat Commun"},{"key":"7561_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","volume":"601","author":"L Xiao","year":"2021","unstructured":"Xiao L, Parolia A, Qiao Y, Bawa P, Eyunni S, Mannan R, et al. Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer. Nature. 2021;601:434\u20139.","journal-title":"Nature"},{"key":"7561_CR19","doi-asserted-by":"publisher","first-page":"10154","DOI":"10.1158\/0008-5472.CAN-08-1794","volume":"68","author":"H Shen","year":"2008","unstructured":"Shen H, Powers N, Saini N, Comstock CES, Sharma A, Weaver K, et al. The SWI\/SNF ATPase Brm Is a gatekeeper of proliferative control in prostate cancer. Cancer Res. 2008;68:10154\u201362.","journal-title":"Cancer Res"},{"key":"7561_CR20","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1093\/carcin\/bgn117","volume":"29","author":"Y Dai","year":"2008","unstructured":"Dai Y, Ngo D, Jacob J, Forman LW, Faller DV. Prohibitin and the SWI\/SNF ATPase subunit BRG1 are required for effective androgen antagonist-mediated transcriptional repression of androgen receptor-regulated genes. Carcinogenesis. 2008;29:1725\u201333.","journal-title":"Carcinogenesis"},{"key":"7561_CR21","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.3390\/biom11121794","volume":"11","author":"N Barma","year":"2021","unstructured":"Barma N, Stone TC, Carmona Echeverria LM, Heavey S. Exploring the value of BRD9 as a biomarker, therapeutic target and co-target in prostate cancer. Biomolecules. 2021;11:1794.","journal-title":"Biomolecules"},{"key":"7561_CR22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1158\/0008-5472.CAN-20-1417","volume":"81","author":"A Alpsoy","year":"2021","unstructured":"Alpsoy A, Utturkar SM, Carter BC, Dhiman A, Torregrosa-Allen SE, Currie MP, et al. BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression. Cancer Res. 2021;81:820\u201333.","journal-title":"Cancer Res"},{"key":"7561_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15237-5","volume":"11","author":"B Sch\u00f6pf","year":"2020","unstructured":"Sch\u00f6pf B, Weissensteiner H, Sch\u00e4fer G, Fazzini F, Charoentong P, Naschberger A, et al. OXPHOS remodeling in high-grade prostate cancer involves mtDNA mutations and increased succinate oxidation. Nat Commun. 2020;11:1487.","journal-title":"Nat Commun"},{"key":"7561_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/pros.24146","volume":"81","author":"HS Basu","year":"2021","unstructured":"Basu HS, Wilganowski N, Robertson S, Reuben JM, Cohen EN, Zurita A, et al. Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activities. Prostate. 2021;81:799\u2013811.","journal-title":"Prostate"},{"key":"7561_CR25","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333.","journal-title":"Science"},{"key":"7561_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2014.18","volume":"3","author":"E Tsouko","year":"2014","unstructured":"Tsouko E, Khan AS, White MA, Han JJ, Shi Y, Merchant FA, et al. Regulation of the pentose phosphate pathway by an androgen receptor\u2013mTOR-mediated mechanism and its role in prostate cancer cell growth. Oncogenesis. 2014;3:e103.","journal-title":"Oncogenesis"},{"key":"7561_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3109\/10409238909082552","volume":"24","author":"C Newgard","year":"1989","unstructured":"Newgard C, Hwang P, Fletterick R. The family of glycogen phosphorylases: structure and function. Crit Rev Biochem Mol Biol. 1989;24:69\u201399.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"7561_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/s42255-023-00863-2","volume":"5","author":"T TeSlaa","year":"2023","unstructured":"TeSlaa T, Ralser M, Fan J, Rabinowitz JD. The pentose phosphate pathway in health and disease. Nat Metab. 2023;5:1275\u201389.","journal-title":"Nat Metab"},{"key":"7561_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110607","volume":"39","author":"C Chen","year":"2022","unstructured":"Chen C, Lai X, Zhang Y, Xie L, Yu Z, Dan S, et al. NADPH metabolism determines the leukemogenic capacity and drug resistance of AML cells. Cell Rep. 2022;39:110607.","journal-title":"Cell Rep"},{"key":"7561_CR30","doi-asserted-by":"publisher","first-page":"5755","DOI":"10.1158\/0008-5472.CAN-17-0150","volume":"77","author":"L Wang","year":"2017","unstructured":"Wang L, Song G, Zhang X, Feng T, Pan J, Chen W, et al. PADI2-mediated citrullination promotes prostate cancer progression. Cancer Res. 2017;77:5755\u201368.","journal-title":"Cancer Res"},{"key":"7561_CR31","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1158\/0008-5472.CAN-20-1965","volume":"81","author":"L Gao","year":"2021","unstructured":"Gao L, Zhang W, Zhang J, Liu J, Sun F, Liu H, et al. KIF15-mediated stabilization of AR and AR-V7 contributes to enzalutamide resistance in prostate cancer. Cancer Res. 2021;81:1026\u201339.","journal-title":"Cancer Res"},{"key":"7561_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41388-019-0991-3","volume":"39","author":"T Feng","year":"2020","unstructured":"Feng T, Zhao R, Sun F, Lu Q, Wang X, Hu J, et al. TXNDC9 regulates oxidative stress-induced androgen receptor signaling to promote prostate cancer progression. Oncogene. 2020;39:356\u201367.","journal-title":"Oncogene"},{"key":"7561_CR33","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.1038\/onc.2014.401","volume":"34","author":"L Wang","year":"2015","unstructured":"Wang L, Song G, Chang X, Tan W, Pan J, Zhu X, et al. The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway. Oncogene. 2015;34:4735\u201345.","journal-title":"Oncogene"},{"key":"7561_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101799","volume":"37","author":"Q Kang","year":"2020","unstructured":"Kang Q, Yang C. Oxidative stress and diabetic retinopathy: molecular mechanisms, pathogenetic role and therapeutic implications. Redox Biol. 2020;37:101799.","journal-title":"Redox Biol"},{"key":"7561_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2017.12.001","volume":"193","author":"E Dehdashtian","year":"2018","unstructured":"Dehdashtian E, Mehrzadi S, Yousefi B, Hosseinzadeh A, Reiter RJ, Safa M, et al. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress. Life Sci. 2018;193:20\u201333.","journal-title":"Life Sci"},{"key":"7561_CR36","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.cmet.2012.10.017","volume":"16","author":"E Favaro","year":"2012","unstructured":"Favaro E, Bensaad K, Chong MG, Tennant DA, Ferguson DJ, Snell C, et al. Glucose utilization via glycogen phosphorylase sustains proliferation and prevents premature senescence in cancer cells. Cell Metab. 2012;16:751\u201364.","journal-title":"Cell Metab"},{"key":"7561_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/ERC-20-0504","volume":"28","author":"RTK Poluri","year":"2021","unstructured":"Poluri RTK, Paquette V, Allain \u00c9P, Lafront C, Joly-Beauparlant C, Weidmann C, et al. KLF5 and NFYA factors as novel regulators of prostate cancer cell metabolism. Endocr Relat Cancer. 2021;28:257\u201371.","journal-title":"Endocr Relat Cancer"},{"key":"7561_CR38","first-page":"922","volume":"136","author":"S He","year":"2023","unstructured":"He S, Yu X, Cui D, Liu Y, Yang S, Zhang H, et al. Nuclear factor-Y mediates pancreatic \u03b2-cell compensation by repressing reactive oxygen species-induced apoptosis under metabolic stress. Chin Med J (Engl). 2023;136:922\u201332.","journal-title":"Chin Med J (Engl)"},{"key":"7561_CR39","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s41388-021-02148-y","volume":"41","author":"J Lin","year":"2022","unstructured":"Lin J, Xia L, Oyang L, Liang J, Tan S, Wu N, et al. The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity. Oncogene. 2022;41:1024\u201339.","journal-title":"Oncogene"},{"key":"7561_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf6290","volume":"7","author":"Y Yuanqin","year":"2021","unstructured":"Yuanqin Y, Meng W, Dongqing C, Chao Y, Jingsi J, Lingling W, et al. ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation. Sci Adv. 2021;7:eabf6290.","journal-title":"Sci Adv"},{"key":"7561_CR41","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/j.ccell.2023.05.016","volume":"41","author":"H Wang","year":"2023","unstructured":"Wang H, Li N, Liu Q, Guo J, Pan Q, Cheng B, et al. Antiandrogen treatment induces stromal cell reprogramming to promote castration resistance in prostate cancer. Cancer Cell. 2023;41:1345\u201362.e9.","journal-title":"Cancer Cell"},{"key":"7561_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/onc.2016.223","volume":"36","author":"PL Martin","year":"2017","unstructured":"Martin PL, Yin JJ, Seng V, Casey O, Corey E, Morrissey C, et al. Androgen deprivation leads to increased carbohydrate metabolism and hexokinase 2-mediated survival in Pten\/Tp53-deficient prostate cancer. Oncogene. 2017;36:525\u201333.","journal-title":"Oncogene"},{"key":"7561_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0635-5","volume":"9","author":"L Mele","year":"2018","unstructured":"Mele L, Paino F, Papaccio F, Regad T, Boocock D, Stiuso P, et al. A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo. Cell Death Dis. 2018;9:572.","journal-title":"Cell Death Dis"},{"key":"7561_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07411-7","volume":"9","author":"H Geng","year":"2018","unstructured":"Geng H, Xue C, Mendonca J, Sun X-X, Liu Q, Reardon PN, et al. Interplay between hypoxia and androgen controls a metabolic switch conferring resistance to androgen\/AR-targeted therapy. Nat Commun. 2018;9:4972.","journal-title":"Nat Commun"},{"key":"7561_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41108-1","volume":"9","author":"M Blignaut","year":"2019","unstructured":"Blignaut M, Loos B, Botchway SW, Parker AW, Huisamen B. Ataxia-telangiectasia mutated is located in cardiac mitochondria and impacts oxidative phosphorylation. Sci Rep. 2019;9:4782.","journal-title":"Sci Rep"},{"key":"7561_CR46","doi-asserted-by":"publisher","first-page":"8788","DOI":"10.1073\/pnas.1003428107","volume":"107","author":"F Weinberg","year":"2010","unstructured":"Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proc Natl Acad Sci USA. 2010;107:8788\u201393.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7561_CR47","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nature03688","volume":"436","author":"DC Radisky","year":"2005","unstructured":"Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, et al. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature. 2005;436:123\u20137.","journal-title":"Nature"},{"key":"7561_CR48","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","volume":"119","author":"M Nieborowska-Skorska","year":"2012","unstructured":"Nieborowska-Skorska M, Kopinski PK, Ray R, Hoser G, Ngaba D, Flis S, et al. Rac2-MRC-cIII\u2013generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors. Blood. 2012;119:4253\u201363.","journal-title":"Blood"},{"key":"7561_CR49","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7561_CR50","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1177\/1534735404270335","volume":"3","author":"KA Conklin","year":"2004","unstructured":"Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther. 2004;3:294\u2013300.","journal-title":"Integr Cancer Ther"},{"key":"7561_CR51","doi-asserted-by":"publisher","first-page":"e81162","DOI":"10.1371\/journal.pone.0081162","volume":"8","author":"W Sobol Robert","year":"2013","unstructured":"Sobol Robert W, Marullo R, Werner E, Degtyareva N, Moore B, Altavilla G, et al. Cisplatin induces a mitochondrial-ROS response that contributes to cytotoxicity depending on mitochondrial redox status and bioenergetic functions. PLoS One. 2013;8:e81162.","journal-title":"PLoS One"},{"key":"7561_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7150\/ijms.3635","volume":"9","author":"R Baskar","year":"2012","unstructured":"Baskar R, Lee KA, Yeo R, Yeoh K-W. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9:193\u20139.","journal-title":"Int J Med Sci"},{"key":"7561_CR53","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/cncr.21324","volume":"104","author":"G Delaney","year":"2005","unstructured":"Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment. Cancer. 2005;104:1129\u201337.","journal-title":"Cancer"},{"key":"7561_CR54","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520:553\u20137.","journal-title":"Nature"},{"key":"7561_CR55","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng L, Liang H, Xu M, Yang X, Burnette B, Arina A, et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity. 2014;41:843\u201352.","journal-title":"Immunity"},{"key":"7561_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39607-x","volume":"14","author":"C Wang","year":"2023","unstructured":"Wang C, Zhang R, He J, Yu L, Li X, Zhang J, et al. Ultrasound-responsive low-dose doxorubicin liposomes trigger mitochondrial DNA release and activate cGAS-STING-mediated antitumour immunity. Nat Commun. 2023;14:3877.","journal-title":"Nat Commun"},{"key":"7561_CR57","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","volume":"366","author":"SL Topalian","year":"2012","unstructured":"Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti\u2013PD-1 antibody in cancer. N Engl J Med. 2012;366:2443\u201354.","journal-title":"N Engl J Med"},{"key":"7561_CR58","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1200\/JCO.19.01638","volume":"38","author":"ES Antonarakis","year":"2020","unstructured":"Antonarakis ES, Piulats JM, Gross-Goupil M, Goh J, Ojamaa K, Hoimes CJ, et al. Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study. J Clin Oncol. 2020;38:395\u2013405.","journal-title":"J Clin Oncol"},{"key":"7561_CR59","doi-asserted-by":"publisher","first-page":"5627","DOI":"10.21037\/tcr-24-1974","volume":"13","author":"T Cao","year":"2024","unstructured":"Cao T, Wang J. PYGL regulation of glycolysis and apoptosis in glioma cells under hypoxic conditions via HIF1alpha-dependent mechanisms. Transl Cancer Res. 2024;13:5627\u201348.","journal-title":"Transl Cancer Res"},{"key":"7561_CR60","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","volume":"39","author":"KC Patra","year":"2014","unstructured":"Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends Biochem Sci. 2014;39:347\u201354.","journal-title":"Trends Biochem Sci"},{"key":"7561_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-64255-6","volume":"14","author":"X Chen","year":"2024","unstructured":"Chen X, Yang N, Wang Y, Yang S, Peng Y. PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy resistance in cervical cancer stem cells. Sci Rep. 2024;14:13670.","journal-title":"Sci Rep"},{"key":"7561_CR62","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3892\/or.2012.1932","volume":"28","author":"J Liu","year":"2012","unstructured":"Liu J, Hou M, Yuan T, Yi G, Zhang S, Shao X, et al. Enhanced cytotoxic effect of low doses of metformin combined with ionizing radiation on hepatoma cells via ATP deprivation and inhibition of DNA repair. Oncol Rep. 2012;28:1406\u201312.","journal-title":"Oncol Rep"},{"key":"7561_CR63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s43018-022-00331-y","volume":"3","author":"N Bonagas","year":"2022","unstructured":"Bonagas N, Gustafsson NMS, Henriksson M, Marttila P, Gustafsson R, Wiita E, et al. Pharmacological targeting of MTHFD2 suppresses acute myeloid leukemia by inducing thymidine depletion and replication stress. Nat Cancer. 2022;3:156\u201372.","journal-title":"Nat Cancer"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07561-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07561-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T04:02:17Z","timestamp":1745294537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07561-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7561"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07561-9","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving animals (D20230117017) were reviewed and approved by the Ethics Committee of Shandong First Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors understand and agree with the content of the paper and agree to be listed as co-authors of the paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"326"}}